| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1248.355 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.355/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355 |
| Version | 20250312 |
| Status | active |
| Date | 2025-03-12T01:08:28-04:00 |
| Name | ChemotherapyAgentsForAdvancedCancer |
| Title | Chemotherapy Agents for Advanced Cancer |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains RxNORM codes associated with chemotherapy agents commonly used to treat patients with advanced stages of cancer.),(Data Element Scope: This would use the Medication QDM category.),(Inclusion Criteria: Inclusion Criteria Inclusion Criteria.The following generic, prescribable chemotherapy agents are included in this value set: altretamine, arsenic trioxide, asparaginase, azacytidine, belinostat, bendamustine, bexarotene, bleomycin, busulfan, cabazitaxel, capecitabine, carboplatin, carmustine, chlorambucil, cisplatin, cladribine, clofarabine, cyclophosphamide, cytarabine, cytarabine liposome, dacarbazine, dactinomycin, daunorubicin, decitabine, docetaxel, doxorubicin, epirubicin, eribulin, estramustine, etoposide, floxuridine, fludarabine, fluorouracil, gemcitabine, hydroxyurea, idarubicin, ifosfamide, irinotecan, ixabepilone, lomustine, mechlorethamine, melphalan, mercaptopurine, methotrexate, mitomycin, mitotane, mitoxantrone, nelarabine, omacetaxine, oxaliplatin, paclitaxel, pegaspargase, pemetrexed, pentostatin, pralatrexate, procarbazine, ruxolitinib, streptozocin, temozolomide, teniposide, thioguanine, thiotepa, topotecan, trabectedin, vinblastine, vincristine.),(Exclusion Criteria: Chemotherapy agents not listed above are excluded from this value set, including brand name drugs or brand name drug packs.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR